Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Updated Guidelines Released for Preventing Surgical Site Infections

By HospiMedica International staff writers
Posted on 02 Feb 2017
The American College of Surgeons and the Surgical Infection Society have updated the guidelines detailing the measures that patients, surgeons, and hospitals can do to prevent surgical site infection (SSI).

Issued dealt by the updated guidelines' recommendations include:

Smokers and former smokers are at higher risk for SSIs. More...
Surgeons should counsel patients to completely refrain from smoking for a minimum of four to six weeks before elective surgery.

Short-term blood glucose control before, during, and after surgery is more important than long-term blood sugar maintenance. There now is high-quality evidence to support expanding blood sugar control to all patients, regardless of diabetic status.

Studies of individual procedures have shown promising results when using topical and local antibiotics to reduce infections.

Hair in the surgical site should be removed only if it would interfere with surgery, as shaving causes microscopic cuts and abrasions, resulting in disruption of the skin's barrier defense against microorganisms. Clippers generally should be used instead of razors to remove hair.

Historically, guidelines have not recommended using antibiotic sutures to decrease SSIs, but there now is considerable evidence to support their use.

Double gloving decreases the risk of holes to the inner glove, so routine double gloving is recommended to protect the surgeon.

Early showering does not increase the risk of SSIs and can be encouraged at the surgeon's discretion.

“SSIs are the most common and costly of all hospital-acquired infections, accounting for 20% of all hospital-acquired infections. They occur in an estimated 2-5% of patients undergoing inpatient surgery,” concluded lead author Kristen Ban, MD, of ACS and Loyola University Medical Center, and colleagues. “Guidelines serve as a starting point for the delivery of evidence-based care, but they are only useful if they are implemented successfully. Hospitals must engage individuals at all levels, from front-line providers to leadership.”

SSI’s are an important source, and may even be the most frequent healthcare-associated infection (HAI) after asymptomatic bacteriuria, representing a high burden on patients and hospitals in terms of morbidity, mortality, prolonged length of hospital stay, and additional costs.

The guidelines were published in January 2017 issue of the Journal of the American College of Surgeons (JACS).


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.